Curis
CRIS
#10310
Rank
A$15.95 M
Marketcap
A$1.23
Share price
-2.73%
Change (1 day)
-77.39%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): A-$5.79

According to Curis's latest financial reports the company's current EPS (TTM) is A-$5.48. In 2024 the company made an earnings per share (EPS) of A-$10.50 an increase over its 2023 EPS that were of A-$13.48.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$5.79-44.86%
2024A-$10.50-22.15%
2023A-$13.48-26.17%
2022A-$18.2622.3%
2021A-$14.93-25.37%
2020A-$20.00-30.93%
2019A-$28.96-2.02%
2018A-$29.56
2016A-$67.18-10%
2015A-$74.65138.1%
2014A-$31.3540%
2013A-$22.39-25%
2012A-$29.8666.67%
2011A-$17.91

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Exelixis
EXEL
A$3.55-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$2.10-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A-$0.54-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A-$5.05-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$2.57-146.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$4.43-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
A-$16.78 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA